These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
33-0264467
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
|
●
|
Our ability to fund our operations in the short and long term through financing transactions on terms acceptable to us, or at all;
|
|
|
●
|
Our history of operating losses and the uncertainty surrounding our ability to achieve or sustain profitability;
|
|
|
●
|
Our limited history of developing and selling products made from our bulk amorphous alloys;
|
|
|
●
|
Lengthy customer adoption cycles and unpredictable customer adoption practices;
|
|
|
●
|
Our ability to identify, develop, and commercialize new product applications for our technology;
|
|
|
●
|
Competition from current suppliers of incumbent materials or producers of competing products;
|
|
|
●
|
Our ability to identify, consummate, and/or integrate strategic partnerships;
|
|
|
●
|
The potential for manufacturing problems or delays; and
|
|
|
●
|
Potential difficulties associated with protecting or expanding our intellectual property position.
|
|
PART I - Financial Information
|
|||
|
Item 1 –
Financial Statements
|
4
|
||
|
20
|
|||
|
26
|
|||
|
Item 4 –
Controls and Procedures
|
26
|
||
|
PART II – Other Information
|
|||
|
Item 1 –
Legal Proceedings
|
27
|
||
|
Item 1A –
Risk Factors
|
27
|
||
|
27
|
|||
|
Item 3 –
Defaults Upon Senior Securities
|
28
|
||
|
Item 4 –
Mine Safety Disclosures
|
28
|
||
|
Item 5 –
Other Information
|
28
|
||
|
Item 6 –
Exhibits
|
28
|
||
|
29
|
|||
|
Item 1 –
|
|
September 30,
|
December 31,
|
|||||||
|
2012
|
2011
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash
|
$ | 8,701 | $ | 122 | ||||
|
Trade accounts receivable, net of allowance for doubtful accounts of $0 and $0
|
98 | 241 | ||||||
|
Related party notes receivable
|
200 | 200 | ||||||
|
Prepaid expenses and other current assets
|
846 | 248 | ||||||
|
Total current assets
|
$ | 9,845 | $ | 811 | ||||
|
Property and equipment, net
|
154 | 162 | ||||||
|
Patents and trademarks, net
|
901 | 968 | ||||||
|
Other assets
|
32 | 52 | ||||||
|
Total assets
|
$ | 10,932 | $ | 1,993 | ||||
|
LIABILITIES AND SHAREHOLDERS' DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
235 | 803 | ||||||
|
Accrued liabilities
|
170 | 457 | ||||||
|
Accrued dividends
|
222 | 571 | ||||||
|
Deferred revenue
|
- | 67 | ||||||
|
Short-term debt
|
- | 1,712 | ||||||
|
Convertible note, net of debt discount of $8,177
|
2,823 | - | ||||||
|
Embedded conversion feature liability
|
6,080 | - | ||||||
|
Total current liabilities
|
$ | 9,530 | $ | 3,610 | ||||
|
Long-term liabilities
|
||||||||
|
Warrant liabilities
|
5,302 | - | ||||||
|
Other long-term liabilities
|
856 | 609 | ||||||
|
Total liabilities
|
$ | 15,688 | $ | 4,219 | ||||
|
Shareholders' deficit:
|
||||||||
|
Convertible, redeemable Series A Preferred Stock, $0.001 par value; 10,000,000shares authorized; 506,936 and 1,299,151 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively
|
- | 1 | ||||||
|
Common stock, $0.001 par value; 400,000,000 shares authorized; 196,962,069and 134,467,554 shares issued and outstanding at September 30, 2012and December 31, 2011, respectively
|
193 | 130 | ||||||
|
Warrants
|
18,179 | 24,438 | ||||||
|
Additional paid-in capital
|
163,771 | 149,064 | ||||||
|
Accumulated deficit
|
(186,899 | ) | (175,859 | ) | ||||
|
Total shareholders' deficit
|
$ | (4,756 | ) | $ | (2,226 | ) | ||
|
Total liabilities and shareholders' deficit
|
$ | 10,932 | $ | 1,993 | ||||
|
For the Three Months
|
For the Nine Months
|
|||||||||||||||
|
Ended September 30,
|
Ended September 30,
|
|||||||||||||||
|
2012
|
2011
|
2012
|
2011
|
|||||||||||||
|
(Restated)
|
(Restated)
|
|||||||||||||||
|
Revenue
|
||||||||||||||||
|
Products
|
$ | 80 | $ | 112 | $ | 471 | $ | 345 | ||||||||
|
Licensing and royalties
|
27 | - | 46 | 381 | ||||||||||||
|
Total revenue
|
107 | 112 | 517 | 726 | ||||||||||||
|
Cost of revenue
|
73 | 43 | 256 | 212 | ||||||||||||
|
Gross profit
|
34 | 69 | 261 | 514 | ||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Selling, marketing, general and administrative
|
1,372 | 877 | 3,338 | 2,741 | ||||||||||||
|
Research and development
|
217 | 273 | 616 | 886 | ||||||||||||
|
Manufacturing contract costs
|
- | - | 6,300 | - | ||||||||||||
|
Settlement expense
|
- | 1,127 | - | 1,712 | ||||||||||||
|
Total operating expenses
|
1,589 | 2,277 | 10,254 | 5,338 | ||||||||||||
|
Operating loss from continuing operations
|
(1,555 | ) | (2,208 | ) | (9,993 | ) | (4,824 | ) | ||||||||
|
Change in value of warrants
|
4,184 | 743 | 4,010 | 1,327 | ||||||||||||
|
Change in value of embedded conversion feature liability
|
2,785 | - | 2,785 | - | ||||||||||||
| Debt discount amortization | (6,247 | ) | - | (6,247 | ) | - | ||||||||||
|
Financing costs
|
- | - | (1,355 | ) | - | |||||||||||
|
Other income
|
- | 20 | - | 26 | ||||||||||||
|
Interest expense
|
(240 | ) | (17 | ) | (258 | ) | (48 | ) | ||||||||
|
Interest income
|
10 | 4 | 18 | 18 | ||||||||||||
|
Loss from continuing operations before income taxes
|
(1,063 | ) | (1,458 | ) | (11,040 | ) | (3,501 | ) | ||||||||
|
Income taxes
|
- | - | - | - | ||||||||||||
|
Loss from continuing operations
|
(1,063 | ) | (1,458 | ) | (11,040 | ) | (3,501 | ) | ||||||||
|
Discontinued operations:
|
||||||||||||||||
|
Loss on disposal of subsidiary, net of tax
|
- | (331 | ) | - | (331 | ) | ||||||||||
|
Loss from operations of discontinued operations, net of taxes
|
- | (96 | ) | - | (637 | ) | ||||||||||
|
Net loss
|
(1,063 | ) | (1,885 | ) | (11,040 | ) | (4,469 | ) | ||||||||
| Other comprehensive income | ||||||||||||||||
|
Foreign exchange translation gain (loss) during the period
|
- | (25 | ) | - | 11 | |||||||||||
|
Comprehensive loss
|
$ | (1,063 | ) | $ | (1,910 | ) | $ | (11,040 | ) | $ | (4,458 | ) | ||||
|
Per common share basic and diluted:
|
||||||||||||||||
|
Loss from continuing operations
|
$ | (0.01 | ) | $ | (0.01 | ) | $ | (0.06 | ) | $ | (0.03 | ) | ||||
|
Loss from discontinued operations
|
- | - | - | - | ||||||||||||
|
Basic and diluted loss per share
|
$ | (0.01 | ) | $ | (0.01 | ) | $ | (0.06 | ) | $ | (0.03 | ) | ||||
|
Number of weighted average shares - basic and diluted
|
195,275,681 | 129,766,480 | 173,544,833 | 113,271,712 | ||||||||||||
|
Preferred Shares
|
Common
Shares
|
Preferred Stock
|
Common
Stock
|
Warrants part of
Additional Paid-in
Capital
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
|
|||||||||||||||||||||||||
|
Balance, December 31, 2011
|
1,299,151 | 134,467,554 | $ | 1 | $ | 130 | $ | 24,438 | $ | 149,064 | $ | (175,859 | ) | $ | (2,226 | ) | ||||||||||||||||
|
Conversion of preferred stock
|
(792,215 | ) | 25,669,752 | (1 | ) | 26 | - | (25 | ) | - | - | |||||||||||||||||||||
|
Common stock issuance
|
- | 35,059,163 | - | 35 | - | 7,778 | - | 7,813 | ||||||||||||||||||||||||
|
Warrant exercises
|
- | 1,411,600 | - | 1 | (6,259 | ) | 6,258 | - | - | |||||||||||||||||||||||
|
Stock option exercises
|
- | 354,000 | - | 1 | - | 43 | - | 44 | ||||||||||||||||||||||||
|
Stock-based compensation
|
- | - | - | - | - | 71 | - | 71 | ||||||||||||||||||||||||
|
Restricted stock issued to officer
|
- | - | - | - | - | 233 | - | 233 | ||||||||||||||||||||||||
|
Dividend distribution
|
- | - | - | - | - | 349 | - | 349 | ||||||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | - | (11,040 | ) | (11,040 | ) | ||||||||||||||||||||||
|
Balance, September 30, 2012
|
506,936 | 196,962,069 | $ | - | $ | 193 | $ | 18,179 | $ | 163,771 | $ | (186,899 | ) | $ | (4,756 | ) | ||||||||||||||||
|
Nine Months Ended September 30,
|
||||||||
|
2012
|
2011
|
|||||||
|
(Restated)
|
||||||||
|
Operating activities:
|
||||||||
|
Net loss
|
$ | (11,040 | ) | $ | (4,469 | ) | ||
|
Add: Loss from disposal of subsidiary and operations of discontinued operations
|
- | 968 | ||||||
|
Net loss attributable to continuing operations
|
$ | (11,040 | ) | $ | (3,501 | ) | ||
|
Adjustments to reconcile loss from continuing operations to net cash (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
138 | 211 | ||||||
|
Stock-based compensation
|
71 | 183 | ||||||
|
Resticted stock compensation issued to officer
|
233 | 233 | ||||||
|
Gain from change in value of warrants
|
(4,010 | ) | (1,327 | ) | ||||
|
Gain from change in value of embedded conversion feature liability
|
(2,785 | ) | - | |||||
|
Manufacturing contract costs
|
6,300 | - | ||||||
| Debt discount amortization | 6,247 | - | ||||||
|
Non-cash interest expense
|
240 | - | ||||||
|
Financing costs
|
1,355 | - | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Trade accounts receivable
|
143 | 1 | ||||||
|
Notes receivable
|
- | (200 | ) | |||||
|
Inventories
|
- | 7 | ||||||
|
Prepaid expenses and other current assets
|
106 | 638 | ||||||
|
Other assets
|
20 | 73 | ||||||
|
Accounts payable and accrued expenses
|
(854 | ) | (1,550 | ) | ||||
|
Deferred revenue
|
(67 | ) | 35 | |||||
|
Other liabilities
|
247 | 1,887 | ||||||
|
Net cash used in continuing operations
|
(3,656 | ) | (3,310 | ) | ||||
|
Changes in net assets and liabilities of discontinued operations
|
- | 265 | ||||||
|
Net cash used in operating activities
|
(3,656 | ) | (3,045 | ) | ||||
|
Investing Activities:
|
||||||||
|
Purchases of property and equipment
|
(29 | ) | (239 | ) | ||||
|
Investment in patents and trademarks
|
(35 | ) | - | |||||
|
Net cash used in investing activities
|
(64 | ) | (239 | ) | ||||
|
Financing Activities:
|
||||||||
|
Proceeds from short-term debt
|
1,050 | - | ||||||
|
Repayment of short-term debt
|
(2,762 | ) | - | |||||
|
Payment of debt issuance costs
|
(1,033 | ) | - | |||||
|
Proceeds from exercise of stock options
|
44 | 12 | ||||||
|
Proceeds from convertible debt issuance
|
12,000 | - | ||||||
|
Proceeds from stock issuance
|
3,000 | 1 | ||||||
|
Net cash provided by continuing operations
|
12,299 | 13 | ||||||
|
Net cash used in financing activities of discontinued operations
|
- | (59 | ) | |||||
|
Net cash provided by (used in) financing activities
|
12,299 | (46 | ) | |||||
|
Effect of foreign exchange translation
|
- | (43 | ) | |||||
|
Net increase (decrease) in cash and cash equivalents
|
8,579 | (3,373 | ) | |||||
|
Cash and cash equivalents at beginning of period
|
122 | 5,072 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 8,701 | $ | 1,699 | ||||
|
Supplemental Schedule of Non-Cash Investing and Financing Activities:
|
||||||||
|
Offering cost in relation to common stock issuance
|
2,905 | - | ||||||
|
Cashless exercise of warrants
|
6,259 | - | ||||||
|
Pre-installment payment of convertible debt through common stock issuance
|
1,240 | - | ||||||
|
1.
|
Description of Business
|
|
2.
|
Basis of Presentation and Recent Accounting Pronouncements
|
|
Level 1 —
|
Quoted prices in active markets for identical assets or liabilities;
|
|
Level 2 —
|
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
|
|
Level 3 —
|
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
|
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
|
Embedded conversion feature liability
|
- | - | - | $ | 6,080 | |||||||||||
|
Warrant liabilities
|
- | - | $ | 5,302 | - | |||||||||||
|
3.
|
Significant Transactions
|
|
4.
|
Liquidity and Going Concern Issues
|
|
5.
|
Prepaid Expenses and Other Current Assets
|
|
6.
|
Patents and Trademarks, net
|
|
7.
|
Short Term Debt
|
|
8.
|
Convertible Note and Embedded Conversion Feature Liability
|
|
Convertible Note
|
Debt Discount
|
Net Total
|
||||||||||
|
Beginning Balance - January 1, 2012
|
$ | - | $ | - | $ | - | ||||||
|
Original valuation - July 2, 2012
|
12,000 | (12,000 | ) | - | ||||||||
|
Pre-issuance - August 31, 2012
|
(1,000 | ) | - | (1,000 | ) | |||||||
|
Amortization
|
- | 3,823 | 3,823 | |||||||||
|
Ending Balance - September, 30, 2012
|
$ | 11,000 | $ | (8,177 | ) | $ | 2,823 | |||||
|
September 30,
2012
|
||||
|
Beginning Balance - January 1, 2012
|
$ | - | ||
|
Original valuation - July 2, 2012
|
8,865 | |||
|
Change in value of embedded conversion feature liability, gain
|
(2,785 | ) | ||
|
Ending Balance - September 30, 2012
|
$ | 6,080 | ||
|
9.
|
Warrant Liability
|
|
Visser MTA
|
July 2, 2012
|
|||||||||||
|
Agreement
|
Private Placement
|
Total
|
||||||||||
|
Beginning Balance - January 1, 2012
|
$ | - | $ | - | - | |||||||
|
Original valuation - June & July 2012
|
4,260 | 5,053 | 9,312 | |||||||||
|
Change in value of warrant liability, gain
|
(1,860 | ) | (2,151 | ) | (4,010 | ) | ||||||
|
Ending Balance - Setember 30, 2012
|
$ | 2,400 | $ | 2,902 | $ | 5,302 | ||||||
|
10.
|
Other Long-term Liabilities
|
|
11.
|
Stock Compensation Plan
|
|
12.
|
Shareholders’ Deficit
|
|
13.
|
Discontinued Operations and Long-Lived Assets to be Disposed of
|
|
14.
|
Loss Per Common Share
|
|
15.
|
Commitments and Contingencies
|
|
16.
|
Related Party Transactions
|
|
●
|
Revenue recognition
|
|
●
|
Allowance for doubtful accounts
|
|
●
|
Impairment of long-lived assets and definite-lived intangibles
|
|
●
|
Deferred tax assets
|
|
●
|
Valuation of embedded convertible feature liability and warrants
|
|
●
|
Share based compensation
|
|
For the three months
ended September 30,
|
For the nine months
ended September 30,
|
|||||||||||||||||||||||||||||||
|
2012
|
2011
|
2012
|
2011
|
|||||||||||||||||||||||||||||
|
in 000's
|
% of Products
Revenue
|
in 000's
|
% of Products
Revenue
|
in 000's
|
% of Products
Revenue
|
in 000's
|
% of Products
Revenue
|
|||||||||||||||||||||||||
|
(Restated)
|
(Restated)
|
|||||||||||||||||||||||||||||||
|
Revenue:
|
||||||||||||||||||||||||||||||||
|
Products
|
$ | 80 | $ | 112 | $ | 471 | $ | 345 | ||||||||||||||||||||||||
|
Licensing and royalties
|
27 | - | 46 | 381 | ||||||||||||||||||||||||||||
|
Total revenue
|
107 | 112 | 517 | 726 | ||||||||||||||||||||||||||||
|
Cost of revenue
|
73 | 91 | % | 43 | 38 | % | 256 | 54 | % | 212 | 61 | % | ||||||||||||||||||||
|
Selling, marketing general and administrative
|
1,372 | 1715 | % | 877 | 783 | % | 3,338 | 709 | % | 2,741 | 794 | % | ||||||||||||||||||||
|
Research and development
|
217 | 271 | % | 273 | 244 | % | 616 | 131 | % | 886 | 257 | % | ||||||||||||||||||||
|
Manufacturing contract costs
|
- | 0 | % | - | 0 | % | 6,300 | 1338 | % | - | 0 | % | ||||||||||||||||||||
|
Settlement expense
|
- | 0 | % | 1,127 | 1006 | % | - | 0 | % | 1,712 | 496 | % | ||||||||||||||||||||
|
Change in value of warrants
|
4,184 | 5230 | % | 743 | 663 | % | 4,010 | 851 | % | 1,327 | 385 | % | ||||||||||||||||||||
|
Change in value of embedded conversion feature liability
|
2,785 | 3481 | % | - | 0 | % | 2,785 | 591 | % | - | 0 | % | ||||||||||||||||||||
| Debt discount amortization | (6,247 | ) | -7809 | % | - | 0 | % | (6,247 | ) | -1326 | % | - | 0 | % | ||||||||||||||||||
|
Financing costs
|
- | 0 | % | - | 0 | % | 1,355 | 288 | % | - | 0 | % | ||||||||||||||||||||
|
Other income
|
- | 0 | % | 20 | 18 | % | - | 0 | % | 26 | 8 | % | ||||||||||||||||||||
|
Interest expense
|
(240 | ) | -300 | % | (17 | ) | -15 | % | (258 | ) | -55 | % | (48 | ) | -14 | % | ||||||||||||||||
|
Interest income
|
10 | 13 | % | 4 | 4 | % | 18 | 4 | % | 18 | 5 | % | ||||||||||||||||||||
|
Loss on disposal of subsidiary, net
|
- | 0 | % | (331 | ) | -296 | % | - | 0 | % | (331 | ) | -96 | % | ||||||||||||||||||
|
Loss from operations of discontinued operations
|
- | 0 | % | (96 | ) | -86 | % | - | 0 | % | (637 | ) | -185 | % | ||||||||||||||||||
|
Item 4 –
|
|
Item 1 –
|
|
Item 1A –
|
|
|
1.
|
On July 2, 2012, we issued and sold $12.0 million in principal amount of Senior Convertible Notes due on September 1, 2013 (the “Convertible Notes”) and Warrants to the purchasers of the Convertible Notes giving them the right to purchase up to an aggregate of 18,750,000 shares of our common stock at an exercise price of $0.384 per share (the “Warrants”). The purchasers of the Convertible Notes and Warrants were Kingsbrook Opportunities Master Fund LP, Hudson Bay Master Fund Ltd., Empery Asset Master Ltd., Hartz Capital Investments, LLC and Iroquois Master Fund Ltd. The aggregate purchase price of the Convertible Notes and Warrants was $12.0 million. The Convertible Notes are convertible at any time at the option of the holder into shares of our common stock at $0.352 per share, subject to adjustment. For additional information regarding the Convertible Notes and the Warrants, please see our Current Report on Form 8-K filed on July 2, 2012.
|
|
|
2.
|
On August 30, 2012, we elected to make our first monthly installment payment under the Senior Convertible Notes in shares of our common stock. Accordingly, on August 31, 2012, we issued 5,059,163 shares of our common stock to the five holders of the Senior Convertible Notes in satisfaction of the $1,240,000 monthly installment payment that was due and payable on October 1, 2012.
|
|
Item 3 –
|
|
Item 4 –
|
|
Item 5 –
|
|
Item 6 –
|
|
Exhibit
Number
|
Description of Document | |
|
Certification of Principal Executive Officer, Thomas Steipp, as required by Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer, Tony Chung, as required by Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Executive Officer, Thomas Steipp, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer, Tony Chung, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101.1
|
The following financial statements from Liquidmetal Technologies, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (unaudited), formatted in XBRL: (i) Consolidated Balance Sheets as of September 30, 2012 and December 31, 2011, (ii) Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2012 and 2011, (iii) Consolidated Statement of Shareholders’ Deficit for the nine months ended September 30, 2012, (iv) Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2011, and (v) Notes to Consolidated Financial Statements.
|
|
LIQUIDMETAL TECHNOLOGIES, INC.
|
|
||
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
Date: November 13, 2012
|
/s/ Thomas Steipp
|
|
|
|
|
Thomas Steipp
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
Date: November 13, 2012
|
/s/ Tony Chung
|
|
|
|
|
Tony Chung
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|